Johnson & Johnson Q2 FY25: where the revenue came from and where it went
The whole income statement of Johnson & Johnson for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Mar 31 – Jun 29, 2025
- Reported
- Jul 24, 2025
Revenue$23.7B
+6% year over year
Gross profit$16.1B
68% margin
Operating profit$6.7B
28% margin
Net profit$5.5B
23% margin
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 23.7 | 100% | +6% |
| Innovative medicine | 15.2 | 64% | +5% |
| Med tech | 8.5 | 36% | +7% |
| Cost of revenue | −7.6 | 32% | |
| Gross profit | 16.1 | 68% margin | −2pp |
| SG&A | −5.9 | 25% | −1pp |
| Other | −3.5 | 15% | +0pp |
| Operating profit | 6.7 | 28% margin | +0pp |
| Interest & other costs | −0.2 | ||
| Tax | −1.0 | ||
| Net profit | 5.5 | 23% margin | +2pp |
304 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest